{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:01:44Z","timestamp":1780930904207,"version":"3.54.1"},"reference-count":152,"publisher":"Wiley","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Chemistry &amp; Biodiversity"],"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Alzheimer's disease (AD) is the main cause of dementia worldwide. AD is a progressive brain neurodegenerative disease due to genetic and environmental factors that induce a progressive accumulation of intracellular hyperphosphorylated tau protein and extracellular amyloid protein (A\u03b2). However, anti\u2010AD medications cannot reverse the fundamental AD neuropathology due to amyloid plaques and related oxidative stress and inflammatory reactions. Thus, targeting other pathways might be reasonable in the management of AD. The serotonin (5\u2010HT) neurotransmitter plays a crucial role in preventing neurodegeneration and related oxidative stress and inflammatory reactions. In addition, the serotonergic system is highly dysregulated in many neurodegenerative diseases, including AD. Deregulation of serotonin synthesis and its receptors is involved in the pathogenesis of AD. Therefore, this review aims to discuss how the serotonergic system is affected in AD, and how 5\u2010HT modulators can reverse AD neuropathology and alleviate the associated neuropsychiatric disorders in AD patients.<\/jats:p>","DOI":"10.1002\/cbdv.202403401","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T10:54:11Z","timestamp":1743504851000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serotonergic Modulators in Alzheimer's Disease: A Hope in the Hopeless Condition"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1188-7036","authenticated-orcid":false,"given":"Najlaa Hamed","family":"Almohmadi","sequence":"first","affiliation":[{"name":"Clinical Nutrition Department College of Applied Medical Sciences Umm Al\u2010Qura University Makkah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al\u2010Kuraishy","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Medicine College of Medicine Mustansiriyah University Baghdad Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al\u2010Gareeb","sequence":"additional","affiliation":[{"name":"Jabir Ibn Hayyan Medical University Kufa Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Medicine College of Medicine Mustansiriyah University Baghdad Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4103-9599","authenticated-orcid":false,"given":"Morkoss M.","family":"Fakhry","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology Faculty of Pharmacy Egyptian Russian University Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Alexiou","sequence":"additional","affiliation":[{"name":"University Centre for Research &amp; Development Chandigarh University Chandigarh\u2010Ludhiana Highway Mohali Punjab India"},{"name":"Department of Research &amp; Development Funogen Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Papadakis","sequence":"additional","affiliation":[{"name":"University Hospital Witten\u2010Herdecke University of Witten\u2010Herdecke Wuppertal Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El\u2010Saber","family":"Batiha","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics Faculty of Veterinary Medicine Damanhour University Damanhour Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"issue":"3","key":"e_1_2_13_2_1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11064-022-03817-4","article-title":"A Potential Link Between Visceral Obesity and Risk of Alzheimer's Disease","volume":"48","author":"Al\u2010Kuraishy H. M.","year":"2023","journal-title":"Neurochemical Research"},{"key":"e_1_2_13_3_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121532","article-title":"Insights on Benzodiazepines' Potential in Alzheimer's Disease","volume":"320","author":"Al\u2010Kuraishy H. M.","year":"2023","journal-title":"Life Sciences"},{"key":"e_1_2_13_4_1","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1494101","article-title":"Amyloid\u2010\u03b2 and Heart Failure in Alzheimer's Disease: The New Vistas","volume":"12","author":"Al\u2010Kuraishy H. M.","year":"2025","journal-title":"Frontiers in Medicine"},{"issue":"7","key":"e_1_2_13_5_1","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1007\/s10571-023-01392-y","article-title":"Primary Hypothyroidism and Alzheimer's Disease: A Tale of Two","volume":"43","author":"Alanazi F. H.","year":"2023","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"3","key":"e_1_2_13_6_1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s10787-023-01163-7","article-title":"Long\u2010Term Use of Metformin and Alzheimer's Disease: Beneficial or Detrimental Effects","volume":"31","author":"Al\u2010Kuraishy H. M.","year":"2023","journal-title":"Inflammopharmacology"},{"issue":"1","key":"e_1_2_13_7_1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s41467-023-37304-3","article-title":"An Aging, Pathology Burden, and Glial Senescence Build\u2010Up Hypothesis for Late Onset Alzheimer's Disease","volume":"14","author":"Lau V.","year":"2023","journal-title":"Nature Communications"},{"issue":"2","key":"e_1_2_13_8_1","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.17993","article-title":"Neprilysin Inhibitors and Risk of Alzheimer's Disease: A Future Perspective","volume":"28","author":"Ali N. H.","year":"2024","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"10","key":"e_1_2_13_9_1","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/brainsci12101290","article-title":"Statins Use in Alzheimer Disease: Bane or Boon From Frantic Search and Narrative Review","volume":"12","author":"Alsubaie N.","year":"2022","journal-title":"Brain Sciences"},{"issue":"1","key":"e_1_2_13_10_1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13098-023-01082-1","article-title":"The Potential Role of Human Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus and Alzheimer's Diseases","volume":"15","author":"Alrouji M.","year":"2023","journal-title":"Diabetology & Metabolic Syndrome"},{"issue":"1","key":"e_1_2_13_11_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10571-024-01489-y","article-title":"Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon","volume":"44","author":"Ali N. H.","year":"2024","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"3","key":"e_1_2_13_12_1","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3390\/ijms22031273","article-title":"The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer's Disease","volume":"22","author":"Bekdash R. A.","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"e_1_2_13_13_1","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/brain\/awac096","article-title":"Reimagining Cholinergic Therapy for Alzheimer's Disease","volume":"145","author":"Giacobini E.","year":"2022","journal-title":"Brain"},{"issue":"3","key":"e_1_2_13_14_1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4103\/1673-5374.320970","article-title":"Pathological Mechanisms and Therapeutic Strategies for Alzheimer's Disease","volume":"17","author":"Ju Y.","year":"2022","journal-title":"Neural Regeneration Research"},{"issue":"1","key":"e_1_2_13_15_1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s10020-022-00497-2","article-title":"Central Nervous System Effects of 5\u2010HT7 Receptors: A Potential target for Neurodegenerative Diseases","volume":"28","author":"Quintero\u2010Villegas A.","year":"2022","journal-title":"Molecular Medicine"},{"issue":"16","key":"e_1_2_13_16_1","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.3390\/ijms22168525","article-title":"Highlighting Immune System and Stress in Major Depressive Disorder, Parkinson's, and Alzheimer's Diseases, With a Connection With Serotonin","volume":"22","author":"Correia A. S.","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"12","key":"e_1_2_13_17_1","first-page":"2023","article-title":"Serotonin Receptors as a Potential Target in the Treatment of Alzheimer's Disease","volume":"88","author":"Eremin D. V.","year":"2023","journal-title":"Biochemistry"},{"issue":"15","key":"e_1_2_13_18_1","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.3390\/ijms22157931","article-title":"The Mechanism of Secretion and Metabolism of Gut\u2010Derived 5\u2010Hydroxytryptamine","volume":"22","author":"Liu N.","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"23","key":"e_1_2_13_19_1","doi-asserted-by":"crossref","first-page":"R1216","DOI":"10.1016\/j.cub.2023.09.068","article-title":"Serotonin","volume":"33","author":"Ligneul R.","year":"2023","journal-title":"Current Biology"},{"issue":"6","key":"e_1_2_13_20_1","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s10571-021-01064-9","article-title":"The Roles of Serotonin in Neuropsychiatric Disorders","volume":"42","author":"Pourhamzeh M.","year":"2022","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"2","key":"e_1_2_13_21_1","first-page":"73","article-title":"Important Functions of Serotonin in the Gastrointestinal Tract","volume":"18","author":"Cingelov\u00e1 Z.","year":"2023","journal-title":"International Journal of Health, New Technologies and Social Work"},{"key":"e_1_2_13_22_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/B978-0-12-821927-0.00009-7","volume-title":"The Complex Interplay Between Gut\u2010Brain, Gut\u2010Liver, and Liver\u2010Brain Axes","author":"Bellini M.","year":"2021"},{"key":"e_1_2_13_23_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.pbr.2021.02.003","article-title":"Anatomical and Neurochemical Organization of the Serotonergic System in the Mammalian Brain and in Particular the Involvement of the Dorsal Raphe Nucleus in Relation to Neurological Diseases","volume":"261","author":"Steinbusch H. W.","year":"2021","journal-title":"Progress in Brain Research"},{"issue":"4","key":"e_1_2_13_24_1","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14525","article-title":"Role of Brain Renin\u2013Angiotensin System in Depression: A New Perspective","volume":"30","author":"Ali N. H.","year":"2024","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"8","key":"e_1_2_13_25_1","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1111\/dom.15630","article-title":"Depression and Type 2 Diabetes: A Causal Relationship and Mechanistic Pathway","volume":"26","author":"Khawagi W. Y.","year":"2024","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"e_1_2_13_26_1","first-page":"393","volume-title":"Handbook of Behavioral Neuroscience","author":"Vanhoutte P. M.","year":"2020"},{"issue":"1","key":"e_1_2_13_27_1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13098-023-01149-z","article-title":"Antidepressants and Type 2 Diabetes: Highways to Knowns and Unknowns","volume":"15","author":"Alruwaili N. S.","year":"2023","journal-title":"Diabetology & Metabolic Syndrome"},{"issue":"1","key":"e_1_2_13_28_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12934-022-01745-0","article-title":"Construction of Cell Factory Capable of Efficiently Converting l\u2010Tryptophan Into 5\u2010Hydroxytryptamine","volume":"21","author":"Wang Y.","year":"2022","journal-title":"Microbial Cell Factories"},{"issue":"6","key":"e_1_2_13_29_1","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.36303\/SAJAA.2020.26.6.S3.2561","article-title":"Serotonin\/5\u2010Hydroxytryptamine (5\u2010HT) Physiology","volume":"26","author":"Redelinghuys C.","year":"2020","journal-title":"Southern African Journal of Anaesthesia and Analgesia"},{"key":"e_1_2_13_30_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108155","article-title":"Central 5\u2010HT Receptors and Their Function; Present and Future","volume":"177","author":"Sharp T.","year":"2020","journal-title":"Neuropharmacology"},{"key":"e_1_2_13_31_1","unstructured":"H. P.Sapkota \u201cThe Role of Serotonin in Synaptic Plasticity: Detailed Characterisation of the Effect of Serotonin on Long\u2010Term Potentiation Across the Hippocampus\u201d (PhD thesis University of Leicester 2022)."},{"issue":"12","key":"e_1_2_13_32_1","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3390\/biom11121914","article-title":"5\u2010HT Receptors and Temperature Homeostasis","volume":"11","author":"Voronova I. P.","year":"2021","journal-title":"Biomolecules"},{"issue":"15","key":"e_1_2_13_33_1","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.3390\/ijms23158814","article-title":"The Implication of 5\u2010HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference","volume":"23","author":"Popova N. K.","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"e_1_2_13_34_1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.molbrainres.2005.04.016","article-title":"Serotonin Receptor Activation Leads to Neurite Outgrowth and Neuronal Survival","volume":"138","author":"Fricker A. D.","year":"2005","journal-title":"Molecular Brain Research"},{"issue":"6","key":"e_1_2_13_35_1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.neuron.2020.09.034","article-title":"Serotonin Receptor 2A Activation Promotes Evolutionarily Relevant Basal Progenitor Proliferation in the Developing Neocortex","volume":"108","author":"Xing L.","year":"2020","journal-title":"Neuron"},{"issue":"12","key":"e_1_2_13_36_1","first-page":"2023","article-title":"Serotonin Receptors as a Potential Target in the Treatment of Alzheimer's Disease","volume":"88","author":"Eremin D. V.","year":"2023","journal-title":"Biochemistry"},{"issue":"7","key":"e_1_2_13_37_1","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1021\/acschemneuro.5b00135","article-title":"Serotonin: A New Hope in Alzheimer's Disease?","volume":"6","author":"Claeysen S.","year":"2015","journal-title":"ACS Chemical Neuroscience"},{"issue":"9","key":"e_1_2_13_38_1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/11590190-000000000-00000","article-title":"Role of Serotonin in Alzheimer's Disease","volume":"25","author":"Geldenhuys W. J.","year":"2011","journal-title":"CNS Drugs"},{"issue":"3","key":"e_1_2_13_39_1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1073\/pnas.0510237103","article-title":"Serotonin 1A Receptors in the Living Brain of Alzheimer's Disease Patients","volume":"103","author":"Kepe V.","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"e_1_2_13_40_1","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/BF00227741","article-title":"Brain Stem Serotonin\u2010Synthesizing Neurons in Alzheimer's Disease: A Clinicopathological Correlation","volume":"84","author":"Halliday G. M.","year":"1992","journal-title":"Acta Neuropathologica"},{"key":"e_1_2_13_41_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102537","article-title":"Serotonin in Depression and Alzheimer's Disease: Focus on SSRI's Beneficial Effects","author":"Tahiri J.","year":"2024","journal-title":"Ageing Research Reviews"},{"issue":"1","key":"e_1_2_13_42_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.b.10068","article-title":"Depression in Alzheimer's Disease: The Effect of Serotonin Receptor Gene Variation","volume":"119","author":"Holmes C.","year":"2003","journal-title":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics"},{"key":"e_1_2_13_43_1","doi-asserted-by":"crossref","first-page":"14968","DOI":"10.1073\/pnas.1107411108","article-title":"Serotonin Signaling is Associated With Lower Amyloid\u2010\u03b2 Levels and Plaques in Transgenic Mice and Humans","volume":"108","author":"Cirrito J. R.","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"e_1_2_13_44_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuropharm.2011.02.026","article-title":"5\u2010HT4 Receptor Agonist Mediated Enhancement of Cognitive Function In Vivo and Amyloid Precursor Protein Processing In Vitro: A Pharmacodynamic and Pharmacokinetic Assessment","volume":"61","author":"Shen F.","year":"2011","journal-title":"Neuropharmacology"},{"key":"e_1_2_13_45_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13195-019-0491-2","article-title":"Neuroinflammation and Amyloid\u2010beta 40 are Associated With Reduced Serotonin Transporter (SERT) Activity in a Transgenic Model of Familial Alzheimer's Disease","volume":"11","author":"Metaxas A.","year":"2019","journal-title":"Alzheimer's Research & Therapy"},{"key":"e_1_2_13_46_1","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.79","article-title":"Increased Hippocampal CA1 Density of Serotonergic Terminals in a Triple Transgenic Mouse Model of Alzheimer's Disease: An Ultrastructural Study","volume":"2","author":"Noristani H. N.","year":"2011","journal-title":"Cell Death & Disease"},{"issue":"8","key":"e_1_2_13_47_1","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.neubiorev.2013.05.008","article-title":"Ascending Monoaminergic Systems Alterations in Alzheimer's Disease. Translating Basic Science Into Clinical Care","volume":"37","author":"Trillo L.","year":"2013","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"11","key":"e_1_2_13_48_1","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.3390\/ijms22115603","article-title":"Inflammasome NLRP3 Potentially Links Obesity\u2010Associated Low\u2010Grade Systemic Inflammation and Insulin Resistance With Alzheimer's Disease","volume":"22","author":"Litwiniuk A.","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"13","key":"e_1_2_13_49_1","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/npp.2010.116","article-title":"Interleukin\u20101 Receptor Activation by Systemic Lipopolysaccharide Induces Behavioral Despair Linked to MAPK Regulation of CNS Serotonin Transporters","volume":"35","author":"Zhu C.\u2010B.","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"e_1_2_13_50_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105185","article-title":"5\u2010HT7 Receptors in Alzheimer's Disease","volume":"150","author":"Solas M.","year":"2021","journal-title":"Neurochemistry International"},{"key":"e_1_2_13_51_1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.npp.1300330","article-title":"Differential Involvement of 5\u2010HT1B\/1D and 5\u2010HT6 Receptors in Cognitive and Non\u2010Cognitive Symptoms in Alzheimer's Disease","volume":"29","author":"Garcia\u2010Alloza M.","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"e_1_2_13_52_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3233\/JAD-2008-14104","article-title":"Involvement of an Altered 5\u2010HT6 Receptor Function in Behavioral Symptoms of Alzheimer's Disease","volume":"14","author":"Marcos B.","year":"2008","journal-title":"Journal of Alzheimer's Disease"},{"key":"e_1_2_13_53_1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.nurt.2008.05.008","article-title":"5\u2010HT6 Receptor Antagonists as Novel Cognitive Enhancing Agents for Alzheimer's Disease","volume":"5","author":"Upton N.","year":"2008","journal-title":"Neurotherapeutics"},{"key":"e_1_2_13_54_1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13195-017-0298-y","article-title":"Serotonin Augmentation Therapy by Escitalopram has Minimal Effects on Amyloid\u2010\u03b2 Levels in Early\u2010Stage Alzheimer's\u2010Like Disease in Mice","volume":"9","author":"Linstow C. U.","year":"2017","journal-title":"Alzheimer's Research & Therapy"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3010609"},{"issue":"2","key":"e_1_2_13_56_1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3233\/JAD-220019","article-title":"Efficacy of Chronic Paroxetine Treatment in Mitigating Amyloid Pathology and Microgliosis in APPSWE\/PS1\u0394E9 Transgenic Mice","volume":"87","author":"Sivasaravanaparan M.","year":"2022","journal-title":"Journal of Alzheimer's Disease"},{"key":"e_1_2_13_57_1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuropharm.2016.05.009","article-title":"Agonist and Antagonist Bind Differently to 5\u2010HT1A Receptors During Alzheimer's Disease: A Post\u2010Mortem Study With PET Radiopharmaceuticals","volume":"109","author":"Vidal B.","year":"2016","journal-title":"Neuropharmacology"},{"key":"e_1_2_13_58_1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.neuropharm.2017.06.021","article-title":"Hippocampal 5\u2010HT1A Receptor Expression Changes in Prodromal Stages of Alzheimer's Disease: Beneficial or Deleterious?","volume":"123","author":"Verdurand M.","year":"2017","journal-title":"Neuropharmacology"},{"key":"e_1_2_13_59_1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neulet.2015.03.064","article-title":"5\u2010HT1B and Other Related Serotonergic Proteins Are Altered in APPswe Mutation","volume":"594","author":"Tajeddinn W.","year":"2015","journal-title":"Neuroscience Letters"},{"issue":"4","key":"e_1_2_13_60_1","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1476-5381.2012.01868.x","article-title":"Distribution of 5\u2010HT 1E Receptors in the Mammalian Brain and Cerebral Vasculature: An Immunohistochemical and Pharmacological Study","volume":"166","author":"Klein M. T.","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"e_1_2_13_61_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.138013","article-title":"Serotonin\u20102B Receptor (5\u2010HT2BR) Expression and Binding in the Brain of APPswe\/PS1dE9 Transgenic Mice and in Alzheimer's Disease Brain Tissue","volume":"844","author":"Anzalone M.","year":"2025","journal-title":"Neuroscience Letters"},{"issue":"7","key":"e_1_2_13_62_1","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00210-023-02411-x","article-title":"The Role of Hippocampal 5\u2010HT1D and 5\u2010HT1F Receptors on Learning and Memory in Rats","volume":"396","author":"Afshar S.","year":"2023","journal-title":"Naunyn\u2010Schmiedeberg's Archives of Pharmacology"},{"issue":"2","key":"e_1_2_13_63_1","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab029","article-title":"Alterations in Dopamine System and in Its Connectivity With Serotonin in a Rat Model of Alzheimer's Disease","volume":"3","author":"Ceyz\u00e9riat K.","year":"2021","journal-title":"Brain Communications"},{"issue":"1","key":"e_1_2_13_64_1","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13286","article-title":"Antiallergic Drug Desloratadine as a Selective Antagonist of 5HT 2A Receptor Ameliorates Pathology of Alzheimer's Disease Model Mice by Improving Microglial Dysfunction","volume":"20","author":"Lu J.","year":"2021","journal-title":"Aging Cell"},{"issue":"5","key":"e_1_2_13_65_1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/jnc.15260","article-title":"Pimavanserin, a 5HT2A Receptor Inverse Agonist, Rapidly Suppresses A\u03b2 Production and Related Pathology in a Mouse Model of Alzheimer's Disease","volume":"156","author":"Yuede C. M.","year":"2021","journal-title":"Journal of Neurochemistry"},{"key":"e_1_2_13_66_1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3233\/JAD-240063","article-title":"The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction","volume":"98","author":"Acquarone E.","year":"2024","journal-title":"Journal of Alzheimer's Disease"},{"issue":"16","key":"e_1_2_13_67_1","doi-asserted-by":"crossref","first-page":"14478","DOI":"10.1021\/acs.jmedchem.4c01244","article-title":"Dual 5\u2010HT2A and 5\u2010HT2C Receptor Inverse Agonist That Affords In Vivo Antipsychotic Efficacy With Minimal hERG Inhibition for the Treatment of Dementia\u2010Related Psychosis","volume":"67","author":"Oguma T.","year":"2024","journal-title":"Journal of Medicinal Chemistry"},{"key":"e_1_2_13_68_1","doi-asserted-by":"crossref","DOI":"10.1002\/alz.087509","article-title":"Serotonin 5\u2010HT2C Receptor Agonism in Presymptomatic APP\/PS1 Mice Rescues Seizure\u2010Induced Premature Mortality Perhaps We Just Plainly State What Is Happening","volume":"20","author":"Sanz A. D.","year":"2024","journal-title":"Alzheimer's & Dementia"},{"issue":"9","key":"e_1_2_13_69_1","first-page":"2019","article-title":"Inhibiting 5\u2010Hydroxytryptamine Receptor 3 Alleviates Pathological Changes of a Mouse Model of Alzheimer's Disease","volume":"18","author":"Liu L. F.","year":"2023","journal-title":"Neural Regeneration Research"},{"key":"e_1_2_13_70_1","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14187","article-title":"Amygdala Neuronal Dyshomeostasis via 5\u2010HT Receptors Mediates Mood and Cognitive Defects in Alzheimer's Disease","volume":"23","author":"Wu X.\u2010R.","year":"2024","journal-title":"Aging Cell"},{"issue":"1","key":"e_1_2_13_71_1","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1038\/s41598-020-59805-7","article-title":"Rational Design of Novel Benzisoxazole Derivatives With Acetylcholinesterase Inhibitory and Serotoninergic 5\u2010HT4 Receptors Activities for the Treatment of Alzheimer's Disease","volume":"10","author":"Lalut J.","year":"2020","journal-title":"Scientific Reports"},{"key":"e_1_2_13_72_1","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1338502","article-title":"5\u2010HT4 Receptor Agonists Treatment Reduces Tau Pathology and Behavioral Deficit in the PS19 Mouse Model of Tauopathy","volume":"18","author":"Jiang S.","year":"2024","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"e_1_2_13_73_1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neurobiolaging.2022.09.007","article-title":"Amyloid \u03b2 Oligomers Disrupt Piriform Cortical Output via a Serotonergic Pathway","volume":"121","author":"Wang X.","year":"2023","journal-title":"Neurobiology of Aging"},{"key":"e_1_2_13_74_1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainresbull.2017.10.004","article-title":"The Effects of the 5\u2010HT7 Receptor on Hippocampal Long\u2010Term Potentiation and Apoptosis in a Rat Model of Alzheimer's Disease","volume":"135","author":"Hashemi\u2010Firouzi N.","year":"2017","journal-title":"Brain Research Bulletin"},{"issue":"5","key":"e_1_2_13_75_1","first-page":"627","article-title":"Potential Cognitive Enhancing and Disease Modification Effects of SSRIs for Alzheimer's Disease","volume":"3","author":"Chow T. W.","year":"2007","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"8","key":"e_1_2_13_76_1","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1111\/dom.15630","article-title":"Depression and Type 2 Diabetes: A Causal Relationship and Mechanistic Pathway","volume":"26","author":"Khawagi W. Y.","year":"2024","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"2","key":"e_1_2_13_77_1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jagp.2013.02.011","article-title":"Depression and Incident Alzheimer Disease: The Impact of Disease Severity","volume":"23","author":"Gracia\u2010Garc\u00eda P.","year":"2015","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"8","key":"e_1_2_13_78_1","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.5958\/0974-360X.2015.00181.X","article-title":"Depression is a Risk Factor for Alzheimer Disease\u2010Review","volume":"8","author":"Sanmugam K.","year":"2015","journal-title":"Research Journal of Pharmacy and Technology"},{"issue":"1","key":"e_1_2_13_79_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/1673-5374.264445","article-title":"Selective Serotonin Reuptake Inhibitors and Alzheimer's Disease","volume":"15","author":"Mdawar B.","year":"2020","journal-title":"Neural Regeneration Research"},{"issue":"36","key":"e_1_2_13_80_1","doi-asserted-by":"crossref","first-page":"14968","DOI":"10.1073\/pnas.1107411108","article-title":"Serotonin Signaling is Associated With Lower Amyloid\u2010\u03b2 Levels and Plaques in Transgenic Mice and Humans","volume":"108","author":"Cirrito J. R.","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"236","key":"e_1_2_13_81_1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008169","article-title":"An Antidepressant Decreases CSF A\u03b2 Production in Healthy Individuals and in Transgenic AD Mice","volume":"6","author":"Sheline Y. I.","year":"2014","journal-title":"Science Translational Medicine"},{"key":"e_1_2_13_82_1","article-title":"Citalopram Ameliorates Impairments in Spatial Memory and Synaptic Plasticity in Female 3xTgAD Mice","volume":"2017","author":"Wei Z.","year":"2017","journal-title":"BioMed Research International"},{"key":"e_1_2_13_83_1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.neuropharm.2017.12.021","article-title":"Citalopram Restores Short\u2010Term Memory Deficit and Non\u2010Cognitive Behaviors in APP\/PS1 Mice While Halting the Advance of Alzheimer's Disease\u2010Like Pathology","volume":"131","author":"Zhang Q.","year":"2018","journal-title":"Neuropharmacology"},{"key":"e_1_2_13_84_1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/glia.22926","article-title":"Regulation of Astrocyte Pathology by Fluoxetine Prevents the Deterioration of Alzheimer Phenotypes in an APP\/PS1 Mouse Model","volume":"64","author":"Qiao J.","year":"2016","journal-title":"Glia"},{"key":"e_1_2_13_85_1","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1007\/s12035-016-9952-9","article-title":"Long\u2010Term Ameliorative Effects of the Antidepressant Fluoxetine Exposure on Cognitive Deficits in 3\u2009\u00d7\u2009TgAD Mice","volume":"54","author":"Jin L.i","year":"2017","journal-title":"Molecular Neurobiology"},{"key":"e_1_2_13_86_1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.trci.2018.04.005","article-title":"Established Amyloid\u2010\u03b2 Pathology is Unaffected by Chronic Treatment With the Selective Serotonin Reuptake Inhibitor Paroxetine","volume":"4","author":"Severino M.","year":"2018","journal-title":"Alzheimer's & Dementia"},{"key":"e_1_2_13_87_1","doi-asserted-by":"crossref","first-page":"13328","DOI":"10.18632\/oncotarget.7798","article-title":"Escitalopram Attenuates \u03b2\u2010Amyloid\u2010Induced Tau Hyperphosphorylation in Primary Hippocampal Neurons Through the 5\u2010HT1A Receptor Mediated Akt\/GSK\u20103\u03b2 Pathway","volume":"7","author":"Wang Y.\u2010J.","year":"2016","journal-title":"Oncotarget"},{"key":"e_1_2_13_88_1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/appi.ajp.2017.17040404","article-title":"Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer's Dementia in Individuals With Previous Depression","volume":"175","author":"Bartels C.","year":"2018","journal-title":"American Journal of Psychiatry"},{"key":"e_1_2_13_89_1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/gps.4709","article-title":"Decreasing Hazards of Alzheimer's Disease With the Use of Antidepressants: Mitigating the Risk of Depression and Apolipoprotein E","volume":"33","author":"Burke S. L.","year":"2018","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"e_1_2_13_90_1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4088\/JCP.13m08562","article-title":"Effects of Antidepressants on Longevity and Dementia Onset Among Adults With Down Syndrome","volume":"75","author":"Tsiouris J. A.","year":"2014","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_2_13_91_1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3233\/JAD-170387","article-title":"Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two\u2010Year Follow\u2010Up in Mild Cognitive Impairment and Alzheimer's Disease Patients With Depressive Symptoms","volume":"65","author":"Brendel M.","year":"2018","journal-title":"Journal of Alzheimer's Disease"},{"issue":"1","key":"e_1_2_13_92_1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41398-022-02050-5","article-title":"The Effect of Citalopram Treatment on Amyloid\u2010\u03b2 Precursor Protein Processing and Oxidative Stress in Human hNSC\u2010Derived Neurons","volume":"12","author":"Elsworthy R. J.","year":"2022","journal-title":"Translational Psychiatry"},{"issue":"9","key":"e_1_2_13_93_1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/ph14090930","article-title":"Antidepressants in Alzheimer's Disease: A Focus on the Role of Mirtazapine","volume":"14","author":"Correia A. S.","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"12","key":"e_1_2_13_94_1","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.3390\/ijms25126542","article-title":"Emerging Therapeutic Potential of Fluoxetine on Cognitive Decline in Alzheimer's Disease: Systematic Review","volume":"25","author":"Bougea A.","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"e_1_2_13_95_1","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s12035-024-04333-y","article-title":"An Expanded Narrative Review of Neurotransmitters on Alzheimer's Disease: The Role of Therapeutic Interventions on Neurotransmission","volume":"62","author":"Akyuz E.","year":"2025","journal-title":"Molecular Neurobiology"},{"issue":"17","key":"e_1_2_13_96_1","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2174\/0929867324666170529122802","article-title":"Multi\u2010Target\u2010Directed Ligands Affecting Serotonergic Neurotransmission for Alzheimer's Disease Therapy: Advances in Chemical and Biological Research","volume":"25","author":"Jankowska A.","year":"2017","journal-title":"Current Medicinal Chemistry"},{"key":"e_1_2_13_97_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40263-016-0399-3","article-title":"Serotonin 5\u2010HT 6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status","volume":"31","author":"Ferrero H.","year":"2017","journal-title":"CNS Drugs"},{"issue":"1","key":"e_1_2_13_98_1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/JAD-230570","article-title":"Serotonin Degeneration and Amyloid\u2010\u03b2 Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits","volume":"96","author":"Smith G. S.","year":"2023","journal-title":"Journal of Alzheimer's Disease"},{"key":"e_1_2_13_99_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2024.09.001","article-title":"Assessing the Efficacy and Safety of Combined Buspirone and Venlafaxine Treatment in Late\u2010Life Depression Accompanied by Cognitive Impairment: A Randomized Controlled Trial","volume":"91","author":"Hu S.","year":"2024","journal-title":"General Hospital Psychiatry"},{"key":"e_1_2_13_100_1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nlm.2013.12.015","article-title":"Improving Cognition in Schizophrenia With Antipsychotics That Elicit Neurogenesis Through 5\u2010HT1A Receptor Activation","volume":"110","author":"Schreiber R.","year":"2014","journal-title":"Neurobiology of Learning and Memory"},{"key":"e_1_2_13_101_1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3389\/fphar.2017.00710","article-title":"Buspirone Counteracts MK\u2010801\u2010Induced Schizophrenia\u2010Like Phenotypes Through Dopamine D3 Receptor Blockade","volume":"8","author":"Torrisi S. A.","year":"2017","journal-title":"Frontiers in Pharmacology"},{"key":"e_1_2_13_102_1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.yrtph.2018.09.017","article-title":"Dose Related Effects of Buspirone on Pain, Learning\/Memory and Food Intake","volume":"99","author":"Haleem D. J.","year":"2018","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"e_1_2_13_103_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40120-013-0015-0","article-title":"Chronic Treatment With the 5\u2010HT1A Receptor Partial Agonist Tandospirone Increases Hippocampal Neurogenesis","volume":"3","author":"Mori M.","year":"2014","journal-title":"Neurology and Therapy"},{"key":"e_1_2_13_104_1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fnbeh.2014.00291","article-title":"Tandospirone, a 5\u2010HT1A Partial Agonist, Ameliorates Aberrant Lactate Production in the Prefrontal Cortex of Rats Exposed to Blockade of N\u2010Methy\u2010d\u2010Aspartate Receptors; Toward the Therapeutics of Cognitive Impairment of Schizophrenia","volume":"8","author":"Uehara T.","year":"2014","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"e_1_2_13_105_1","article-title":"Augmentation Therapy With Serotonin1A Receptor Partial Agonists on Neurocognitive Function in Schizophrenia: A Systematic Review and Meta\u2010Analysis","volume":"34","author":"Yamada R.","year":"2023","journal-title":"Schizophrenia Research: Cognition"},{"issue":"1","key":"e_1_2_13_106_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1586\/14737175.3.1.19","article-title":"Buspirone in Alzheimer's Disease","volume":"3","author":"Desai A. K.","year":"2003","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"5","key":"e_1_2_13_107_1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1017\/S1041610216002441","article-title":"Buspirone for the Treatment of Dementia With Behavioral Disturbance","volume":"29","author":"Santa Cruz M. R.","year":"2017","journal-title":"International Psychogeriatrics"},{"issue":"12","key":"e_1_2_13_108_1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jpsychires.2012.08.013","article-title":"An Exploratory Study of Combination Buspirone and Melatonin SR in Major Depressive Disorder (MDD): A Possible Role for Neurogenesis in Drug Discovery","volume":"46","author":"Fava M.","year":"2012","journal-title":"Journal of Psychiatric Research"},{"issue":"6","key":"e_1_2_13_109_1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.euroneuro.2009.01.013","article-title":"The Partial 5\u2010HT1A Receptor Agonist Buspirone Enhances Neurogenesis in the Opossum (Monodelphis domestica)","volume":"19","author":"Grabiec M.","year":"2009","journal-title":"European Neuropsychopharmacology"},{"issue":"3","key":"e_1_2_13_110_1","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3390\/ijms23031845","article-title":"The Anxiolytic Drug Buspirone Prevents Rotenone\u2010Induced Toxicity in a Mouse Model of Parkinson's Disease","volume":"23","author":"Thomas Broome S.","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"e_1_2_13_111_1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jchemneu.2019.01.008","article-title":"Protective Effects of 5\u2010HT1A Receptor Antagonist and 5\u2010HT2A Receptor Agonist on the Biochemical and Histological Features in a Rat Model of Alzheimer's Disease","volume":"96","author":"Afshar S.","year":"2019","journal-title":"Journal of Chemical Neuroanatomy"},{"issue":"2","key":"e_1_2_13_112_1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.36150\/2499-6564-N320","article-title":"Trazodone: A Multifunctional Antidepressant. Evaluation of Its Properties and Real\u2010World Use","volume":"69","author":"Cuomo A.","year":"2021","journal-title":"Journal of Gerontology and Geriatrics"},{"issue":"12","key":"e_1_2_13_113_1","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jagp.2013.12.174","article-title":"Trazodone Improves Sleep Parameters in Alzheimer Disease Patients: A randomized, Double\u2010Blind, and Placebo\u2010Controlled Study","volume":"22","author":"Camargos E. F.","year":"2014","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"2","key":"e_1_2_13_114_1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.archger.2007.07.010","article-title":"Trazodone for Alzheimer's Disease: A naturalistic Follow\u2010Up Study","volume":"47","author":"L\u00f3pez\u2010Pousa S.","year":"2008","journal-title":"Archives of Gerontology and Geriatrics"},{"issue":"11","key":"e_1_2_13_115_1","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00228-021-03161-6","article-title":"The Effects of Trazodone on Human Cognition: A Systematic Review","volume":"77","author":"Gon\u00e7alo A. M. G.","year":"2021","journal-title":"European Journal of Clinical Pharmacology"},{"key":"e_1_2_13_116_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108218","article-title":"The Antidepressant Drug; Trazodone Inhibits Tau Amyloidogenesis: Prospects for Prophylaxis and Treatment of AD","volume":"679","author":"Akbari V.","year":"2020","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"23","key":"e_1_2_13_117_1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312987","article-title":"Role of Receptors in Relation to Plaques and Tangles in Alzheimer's Disease Pathology","volume":"22","author":"Sharma K.","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"e_1_2_13_118_1","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1251075","article-title":"Anxiety and Alzheimer's Disease Pathogenesis: Focus on 5\u2010HT and CRF Systems in 3xTg\u2010AD and TgF344\u2010AD Animal Models","volume":"15","author":"Reyna N. C.","year":"2023","journal-title":"Frontiers in Aging Neuroscience"},{"key":"e_1_2_13_119_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107171","article-title":"Serotonergic Dysfunction May Mediate the Relationship Between Alcohol Consumption and Alzheimer's Disease","volume":"203","author":"Pierson S. R.","year":"2024","journal-title":"Pharmacological Research"},{"key":"e_1_2_13_120_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.phrs.2015.03.010","article-title":"Glycogen Synthase Kinase\u20103 Beta (GSK\u20103\u03b2) Signaling: Implications for Parkinson's Disease","volume":"97","author":"Golpich M.","year":"2015","journal-title":"Pharmacological Research"},{"key":"e_1_2_13_121_1","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1209703","article-title":"The Role of Glycogen Synthase Kinase 3 Beta in Neurodegenerative Diseases","volume":"16","author":"Yu H.","year":"2023","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"7","key":"e_1_2_13_122_1","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00210-023-02411-x","article-title":"The Role of Hippocampal 5\u2010HT1D and 5\u2010HT1F Receptors on Learning and Memory in Rats","volume":"396","author":"Afshar S.","year":"2023","journal-title":"Naunyn\u2010Schmiedeberg's Archives of Pharmacology"},{"issue":"5","key":"e_1_2_13_123_1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/jn.00805.2018","article-title":"5\u2010HT1D Receptors Inhibit the Monosynaptic Stretch Reflex by Modulating C\u2010Fiber Activity","volume":"121","author":"Lucas\u2010Osma A. M.","year":"2019","journal-title":"Journal of Neurophysiology"},{"issue":"2","key":"e_1_2_13_124_1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/14737175.2018.1414601","article-title":"Dysautonomia in the Pathogenesis of Migraine","volume":"18","author":"Gazerani P.","year":"2018","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"7","key":"e_1_2_13_125_1","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1007\/s00415-023-11706-1","article-title":"Migraine: From Pathophysiology to Treatment","volume":"270","author":"Puledda F.","year":"2023","journal-title":"Journal of Neurology"},{"issue":"2","key":"e_1_2_13_126_1","article-title":"Revisiting Migraine: The Evolving Pathophysiology and the Expanding Management Armamentarium","volume":"15","author":"Gawde P.","year":"2023","journal-title":"Cureus"},{"issue":"9","key":"e_1_2_13_127_1","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.3390\/nu15092140","article-title":"Zinc and Central Nervous System Disorders","volume":"15","author":"Wang B.","year":"2023","journal-title":"Nutrients"},{"issue":"2","key":"e_1_2_13_128_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1570159X20666220411083922","article-title":"Strategies for Treatment of Disease\u2010Associated Dementia Beyond Alzheimer's Disease: An Update","volume":"21","author":"Khan S. S.","year":"2022","journal-title":"Current Neuropharmacology"},{"issue":"3","key":"e_1_2_13_129_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.neuropharm.2011.01.025","article-title":"Implication of 5\u2010HT2B Receptors in the Serotonin Syndrome","volume":"61","author":"Diaz S. L.","year":"2011","journal-title":"Neuropharmacology"},{"issue":"4","key":"e_1_2_13_130_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0736-5748(01)00022-3","article-title":"Developmentally Regulated Serotonin 5\u2010HT 2B Receptors","volume":"19","author":"Nebigil C. G.","year":"2001","journal-title":"International Journal of Developmental Neuroscience"},{"issue":"1","key":"e_1_2_13_131_1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1523\/JNEUROSCI.20-01-00294.2000","article-title":"Serotonin and the 5\u2010HT2B Receptor in the Development of Enteric Neurons","volume":"20","author":"Fiorica\u2010Howells E.","year":"2000","journal-title":"Journal of Neuroscience"},{"issue":"4","key":"e_1_2_13_132_1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/ph4040603","article-title":"Role of 5\u2010HT3 Receptors in the Antidepressant Response","volume":"4","author":"B\u00e9try C.","year":"2011","journal-title":"Pharmaceuticals"},{"key":"e_1_2_13_133_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1201\/9781003096276-17","volume-title":"Textbook of Ion Channels Volume II: Properties, Function, and Pharmacology of the Superfamilies","author":"Mesoy S. M.","year":"2023"},{"key":"e_1_2_13_134_1","unstructured":"N. G.Bowery \u201c5\u2010HT3 Receptors\u201d (2016):149\u2013168."},{"issue":"1","key":"e_1_2_13_135_1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/cn300095t","article-title":"5\u2010HT4 Receptors Constitutively Promote the Non\u2010Amyloidogenic Pathway of APP Cleavage and Interact With ADAM10","volume":"4","author":"Cochet M.","year":"2013","journal-title":"ACS Chemical Neuroscience"},{"issue":"1","key":"e_1_2_13_136_1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0531-5565(02)00157-2","article-title":"The Serotonin 5\u2010HT4 Receptor and the Amyloid Precursor Protein Processing","volume":"38","author":"Lezoualc'h F.","year":"2003","journal-title":"Experimental Gerontology"},{"issue":"7","key":"e_1_2_13_137_1","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.neurobiolaging.2013.01.020","article-title":"Chronic 5\u2010HT4 Receptor Activation Decreases A\u03b2 Production and Deposition in hAPP\/PS1 Mice","volume":"34","author":"Tesseur I.","year":"2013","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"e_1_2_13_138_1","doi-asserted-by":"crossref","DOI":"10.1038\/srep38048","article-title":"Evaluation of Association of Common Variants in HTR1A and HTR5A With Schizophrenia and Executive Function","volume":"6","author":"Guan F.","year":"2016","journal-title":"Scientific Reports"},{"issue":"3","key":"e_1_2_13_139_1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.pharmthera.2005.12.006","article-title":"5\u2010ht5A Receptors as a Therapeutic Target","volume":"111","author":"Thomas D.","year":"2006","journal-title":"Pharmacology & Therapeutics"},{"issue":"3","key":"e_1_2_13_140_1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pharmthera.2005.05.001","article-title":"5\u2010HT6 Receptors: A Novel Target for Cognitive Enhancement","volume":"108","author":"Mitchell E. S.","year":"2005","journal-title":"Pharmacology & Therapeutics"},{"issue":"2","key":"e_1_2_13_141_1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.npp.1300330","article-title":"Differential Involvement of 5\u2010HT1B\/1D and 5\u2010HT6 Receptors in Cognitive and Non\u2010Cognitive Symptoms in Alzheimer's Disease","volume":"29","author":"Garcia\u2010Alloza M.","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"e_1_2_13_142_1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40263-020-00707-7","article-title":"Management of Dementia\u2010Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates","volume":"34","author":"Marcinkowska M.","year":"2020","journal-title":"CNS Drugs"},{"issue":"1","key":"e_1_2_13_143_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s41983-024-00848-2","article-title":"The Role of Neurotransmitter Receptors in Antipsychotic Medication Efficacy for Alzheimer's\u2010Related Psychosis","volume":"60","author":"Sharma B.","year":"2024","journal-title":"Egyptian Journal of Neurology, Psychiatry and Neurosurgery"},{"key":"e_1_2_13_144_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128275","article-title":"Chemical Update on the Potential for Serotonin 5\u2010HT6 and 5\u2010HT7 Receptor Agents in the Treatment of Alzheimer's Disease","volume":"49","author":"Kucwaj\u2010Brysz K.","year":"2021","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"e_1_2_13_145_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105185","article-title":"5\u2010HT7 Receptors in Alzheimer's Disease","volume":"150","author":"Solas M.","year":"2021","journal-title":"Neurochemistry International"},{"issue":"11","key":"e_1_2_13_146_1","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.3390\/biomedicines12112455","article-title":"Unraveling the Serotonergic Mechanism of Stress\u2010Related Anxiety: Focus on Co\u2010Treatment With Resveratrol and Selective Serotonin Reuptake Inhibitors","volume":"2024","author":"Tseilikman V. E.","year":"2024","journal-title":"Biomedicines"},{"key":"e_1_2_13_147_1","doi-asserted-by":"crossref","unstructured":"L.Li H.Geng M.Chen W.Hu andQ.Ye\u201cCognitive Behavioral Therapy Combined With Selective Serotonin Reuptake Inhibitors for Premature Ejaculation: A Systematic Review and Meta\u2010Analysis \u201dAndrology(2024).","DOI":"10.1111\/andr.13787"},{"key":"e_1_2_13_148_1","volume-title":"Serotonin\u2014Neurotransmitter Horm Brain, Bowels Blood","author":"Tanveer J.","year":"2024"},{"issue":"11","key":"e_1_2_13_149_1","first-page":"1124","article-title":"5\u2010HT4 Receptor Agonist Effects on Functional Connectivity in the Human Brain: Implications for Procognitive Action","volume":"8","author":"Cates A. N.","year":"2023","journal-title":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"},{"issue":"4","key":"e_1_2_13_150_1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/ph16040603","article-title":"Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders","volume":"2023","author":"Mlambo R.","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"17","key":"e_1_2_13_151_1","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.3390\/ijms25179427","article-title":"Obstructive Sleep Apnea and Serotoninergic Signalling Pathway: Pathomechanism and Therapeutic Potential","volume":"2024","author":"Witkowska A.","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"e_1_2_13_152_1","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4572471","article-title":"Dissecting Sex\u2010Related Cognition between Alzheimer's Disease and Diabetes: From Molecular Mechanisms to Potential Therapeutic Strategies","volume":"2021","author":"Ashraf G.","year":"2021","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"e_1_2_13_153_1","first-page":"3","article-title":"Molecular imaging of the human emotion circuit","author":"Nummenmaa L.","year":"2020","journal-title":"Social and Affective Neuroscience of Everyday Human Interaction"}],"container-title":["Chemistry &amp; Biodiversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cbdv.202403401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T19:20:14Z","timestamp":1748978414000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cbdv.202403401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":152,"alternative-id":["10.1002\/cbdv.202403401"],"URL":"https:\/\/doi.org\/10.1002\/cbdv.202403401","archive":["Portico"],"relation":{},"ISSN":["1612-1872","1612-1880"],"issn-type":[{"value":"1612-1872","type":"print"},{"value":"1612-1880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"2024-12-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e03401"}}